Data as of Dec 06
| +1.38 / +6.54%|
The 4 analysts offering 12-month price forecasts for Biospecifics Technologies Corp have a median target of 28.50, with a high estimate of 50.00 and a low estimate of 23.50. The median estimate represents a +26.84% increase from the last price of 22.47.
The current consensus among 4 polled investment analysts is to Buy stock in Biospecifics Technologies Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.